U104 Neonatal Dermatology: Case-Based Discussions
DESCRIPTION
This interactive session has the objective of helping recognize common and uncommon neonatal dermatology diseases, allowing the audience to participate, in a friendly manner, challenging their skills and knowledge. Interesting and difficult neonatal cases will be presented, so get ready to participate and share your knowledge.
LEARNING OBJECTIVES
Recognize and diagnose common and uncommon neonatal dermatosis
Broaden the differential diagnosis of neonatal dermatosis
Differentiate between common and uncommon neonatal dermatosis and be able to recognize potentially life threatening diseases and markers of internal diseases
DIRECTOR
Paula Carolina Luna, MD, IFAAD
SPEAKERS
Margarita M Larralde, MD, IFAAD
Antonio Torrelo, MD
DISCLOSURES
Margarita M Larralde, MD, IFAAD
Eli Lilly and Company – Investigator(Honoraria); Galderma Argentina, S.A. – Speaker(Fees); Genzyme Corporation – Speaker(Fees); La Roche-Posay Laboratorie Pharmaceutique – Speaker(Fees); Novartis – Investigator(Honoraria); Pierre Fabre Dermatologie – Speaker(Fees);
Paula Carolina Luna, MD, IFAAD
AbbVie – Advisory Board(Honoraria), Investigator(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Investigator(Fees); Eli Lilly and Company – Investigator(Fees), Speaker(Honoraria); Genzyme Corporation – Speaker/Faculty Education(Honoraria); Janssen-Cilag – Advisory Board(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria); Novartis – Investigator(Fees), Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pierre Fabre Dermatologie – Speaker(Honoraria); Sanofi – Investigator(Fees), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Fees);
Antonio Torrelo, MD
Ferrer – Advisory Board(Honoraria); ISDIN – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pierre Fabre Dermatologie – Speaker(Honoraria); Sanofi – Speaker(Honoraria); Viatris Inc. – Speaker(Honoraria);